CliffBio
small molecule

CHOLBAM

CHOLIC ACID

Loss of exclusivity—loss of exclusivity
CompanyMirum Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameCHOLBAM
Active ingredientCHOLIC ACID
Strength50MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalMarch 2015
Marketing statusRX

More from Mirum Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CHOLBAM patent cliff — loss of exclusivity — | CliffBio